Search Results
Mar 26, 2026, 08:16 ET Ambit Semiconductors Expands Operations into the United States, Marking a Major Milestone in Global Growth
partners, and semiconductor innovators across the region."Expanding into the U.S. represents an exciting new chapter for Ambit," said Saseendra J, CEO of Ambit. "The American market is a global centre for semiconductor innovation and opportunity. Our presence in Austin strengthens our ability to
More news about: Ambit Semiconductors Private Limited
Mar 26, 2026, 07:30 ET Soligenix Receives Orphan Drug Designation from the European Commission for SGX945 for the Treatment of Behçet's Disease
treatment is available."We are extremely pleased to have received European orphan drug designation for the SGX945 program," stated Christopher J. Schaber, PhD, President and Chief Executive Officer of Soligenix. "Behçet's Disease is an area of unmet medical need, with up to 18,000 people in the
More news about: SOLIGENIX, INC.
Mar 26, 2026, 06:00 ET Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over Sham
data package speaks volumes about the robustness of the data and the operational approach the team brought to the conduct of both studies," said Dr. J. Pablo Velazquez-Martin, Chief Medical Officer of Kodiak Sciences. "The strong outcomes in GLOW2 are likely driven by thoughtful refinements to both regimen
More news about: Kodiak Sciences Inc.
Mar 26, 2026, 03:00 ET Allergan Aesthetics Ushers in a New Age of Hyaluronic Acid (HA) Injectables with JUVÉDERM® at AMWC Monaco
Clin Cosmet Investig Dermatol. 2021;14:1105–18.Ogilvie P et al. Aesthet Surg J. 2020;40: NP499–510.Dhillon B and Patel T. J Clin Aesthet Dermatol. 2020;13:33–40.Urdiales-Gálvez F et al. J Cosmet Dermatol. 2023;22(8):2186–97.Allergan Aesthetics. Data on file. HArmonyCaTM
More news about: AbbVie
Mar 26, 2026, 02:01 ET Norgine announces Swissmedic approval of PEDMARQSI® for the prevention of cisplatin induced hearing loss in children
https://www.ema.europa.eu/en/medicines/human/EPAR/pedmarqsi#product-info. Accessed March 2026Brock PR, et al. N Engl J Med 2018; 378(25): 2376–2385Freyer DR, et al. Lancet Oncol 2017; 18(1): 63–74EMA. PEDMARQSI. Available at:
More news about: Norgine
Mar 26, 2026, 02:01 ET Norgine gibt die Swissmedic-Zulassung von PEDMARQSI® zur Vorbeugung von cisplatininduziertem Hörverlust bei Kindern bekannt
https://www.ema.europa.eu/en/medicines/human/EPAR/pedmarqsi#product-info. Zugriff im März 2026Brock PR, et al. N Engl J Med 2018; 378(25): 2376–2385Freyer DR, et al. Lancet Oncol 2017; 18(1): 63–74EMA. PEDMARQSI. Verfügbar auf:
More news about: Norgine
Mar 26, 2026, 02:01 ET Norgine annonce l'approbation par Swissmedic de PEDMARQSI® pour la prévention de la perte auditive induite par le cisplatine chez les enfants
https://www.ema.europa.eu/en/medicines/human/EPAR/pedmarqsi#product-info. Accédé en mars 2026Brock PR, et al. N Engl J Med 2018 ; 378(25) : 2376–2385Freyer DR, et al. Lancet Oncol 2017 ; 18(1) : 63–74EMA. PEDMARQSI. Disponible sur :
More news about: Norgine
Mar 25, 2026, 18:19 ET ABET Launches Recognition of Credentials Service for Micro-Credential Quality Assurance
clarity in a fast-growing credential marketplace, and ABET helps provide that confidence through independent quality assurance," says Dr. Michael K. J. Milligan, CEO of ABET. "Our Recognition of Credentials service gives employers and learners confidence that these skill-based educational experiences
More news about: ABET
Mar 25, 2026, 16:05 ET Precigen Reports Full Year 2025 Financial Results and Business Updates
coverage now extends to approximately 90% of insured lives in the US.J-code assigned: The Centers for Medicare and Medicaid Services has assigned a permanent J-code, J3404, to PAPZIMEOS, effective April 1, 2026. J-codes are standardized reimbursement codes that allow healthcare providers to
More news about: Precigen, Inc.
Mar 25, 2026, 16:05 ET DIAMONDROCK HOSPITALITY RECEIVES NAREIT'S 2026 LEADER IN THE LIGHT AWARD
estate and infrastructure investments worldwide."We are deeply honored to receive Nareit's 2026 Leader in the Light Award once again," said Jeffrey J. Donnelly, Chief Executive Officer of DiamondRock Hospitality Company. "This recognition of leading transparency, together with our top ranking by GRESB
More news about: DiamondRock Hospitality Company
Mar 25, 2026, 16:05 ET Cyngn Reports 2025 Fourth Quarter and Year-End Financial Results
G&J Pepsi and
More news about: Cyngn
Mar 25, 2026, 16:05 ET CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
XU.S. Company Contact:Peter J. Mariani, Chief Financial Officer305 College Road EastPrinceton, NJ 08540
More news about: Cytosorbents Corp
Mar 25, 2026, 12:29 ET NEW Smirnoff Ice Icy Island Just Crashed Beach Destinations with Reality TV's Hottest Stars -- and Tropical Flavor in Tow
in beverage alcohol with an outstanding collection of brands across spirits and beer categories. These brands include Johnnie Walker, Crown Royal, J&B and Buchanan's whiskies, Smirnoff and Ketel One vodkas, Captain Morgan, Baileys, Don Julio, Tanqueray and Guinness.Diageo is a global company,
More news about: Smirnoff Ice
Mar 25, 2026, 11:23 ET Michter's Distillery zal in 2026 twee Legacy Series-whisky's uitbrengen: Shenk's Homestead en Bomberger's Declaration
Legacy Series eert."Elk jaar kijkt ons productieteam uit naar het werken aan deze speciale releases van Shenk's en Bomberger's", aldus Joseph J. Magliocco, President van Michter's. "Ze benadrukken echt de creativiteit van onze distilleerders. Hoewel elk van deze whisky's van jaar tot jaar heel
More news about: Michter's Distillery
Mar 25, 2026, 10:34 ET Michter's 釀酒廠將推出 Legacy Series 的兩款 2026 年版威士忌：Shenk's Homestead 及 Bomberger's Declaration
於賓夕法尼亞州創辦了 Shenk's 釀酒廠。 這間釀酒廠在 19 世紀時改名為 Bomberger's 釀酒廠，其後在 20 世紀中期易名為 Michter's 釀酒廠。 Michter's Legacy Series，正是向這段歷史傳承致敬。Michter's 總裁 Joseph J. Magliocco 評論道：「每年，我們的生產團隊都期待參與釀製 Shenk's 和 Bomberger's 的特別版。 這些作品真正彰顯我們釀酒師的創意才華。 儘管這些威士忌每年都保持一脈相承的特色，但由於釀酒廠不斷試驗，每個年份的版本都各具獨特韻味。」Michter's 首席釀酒師
More news about: Michter's Distillery
Mar 25, 2026, 10:26 ET La distilleria Michter's presenterà l'edizione 2026 di due whiskey della Legacy Series: Homestead di Shenk's e Declaration di Bomberger's
produzione attende con entusiasmo di lavorare a queste edizioni speciali di Shenk's e Bomberger's", ha commentato il presidente di Michter's, Joseph J. Magliocco. "Queste etichette mettono in risalto la creatività dei nostri distillatori. Pur mantenendo caratteristiche comuni anno dopo anno, ogni nuova
More news about: Michter's Distillery
Mar 25, 2026, 10:15 ET Michter's Distillery、レガシーシリーズのウイスキー2種類の2026年版を発売へ: 「Shenk's Homestead」&「Bomberger's Declaration」
Distilleryと改名され、20世紀半ばに再びMichter's Distilleryへと名称が変更されました。 これが、Michter'sのレガシーシリーズが称える歴史的背景です。「当社の製造チームは毎年、Shenk'sとBomberger'sの特別リリースに取り組むことを楽しみにしています」と、Michter'sの社長Joseph J. Maglioccoは述べています。「これらの製品は、当社の蒸留士たちの創造性を際立たせるものです。毎年のウイスキーには共通点がある一方で、蒸留所で行われる試験的な取り組みによって、それぞれのリリースは少しずつ異なる仕上がりとなっています。」Michter'sのマスター・ディスティラーであるDan
More news about: Michter's Distillery
Mar 25, 2026, 10:15 ET The $11B Mining Pivot: Why Capital is Securing High-Grade Gold & Silver Assets
copper."Today marks an important milestone in Coeur's transformation to the sector's newest senior precious metals producer," said Mitchell J. Krebs, Chairman, President and CEO of Coeur Mining. "The tremendous free cash flow profile from our combined platform of seven North American
More news about: USA News Group
Mar 25, 2026, 10:07 ET VectorWave Emerges from Stealth with Breakthrough Neuromorphic Analog Platform for Real-Time Edge AI Directly on RF Signals
architectures designed for the increasingly complex world of wireless connectivity. The company recently closed a $2.5 million seed funding round led by J2 Ventures (www.j2vp.com) and Coalition Ventures (
More news about: VectorWave
Mar 25, 2026, 09:30 ET Women in Healthcare Campaign Launches Headlined by Kahyun Kim
work-life balance, and underinvestment in women's health research.Featured Experts & Voices Include:Kahyun KimDeanna J. Wathington, M.D., M.P.H., FAAFPSian Jones-Jobst, M.D., FAAPAmi Bhatt, M.D., FACCEileen Barrett, M.D., M.P.H.Dr. Carla
More news about: Mediaplanet
Mar 25, 2026, 09:00 ET OncoLux Enters into Know-How Agreement to Advance Optical Theranostics in Robotic Bronchoscopy
Treat capability.The collaboration is planned to commence early in 2026, with Mayo Clinic investigators Janani S. Reisenauer, M.D. and Matthew J. Aizpuru, M.D.Mayo Clinic has a financial interest in the technology referenced in this press release. Mayo Clinic will use any revenue it receives
More news about: OncoLux
Mar 25, 2026, 09:00 ET Merlin CP-GEP™ Demonstrates Superior Predictive Accuracy for Sentinel Lymph Node Metastasis in Early-Stage Melanoma
2024(6) Landow S.M. et al. Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992-2013. J Am Acad Dermatol. 2017; 76: 258-263Media ContactICR HealthcareAlexis Feinberg+1 203-939-2225
More news about: SkylineDx
Mar 25, 2026, 08:57 ET Children's Hospital of Philadelphia Researchers Uncover "Leaky Pipeline" of Escalating Disparities Across the Care Pathway for Pediatric Head Injury Patients
Daniel J. Corwin, MD, MSCE, director of clinical and translational research in the
More news about: Children's Hospital of Philadelphia
Mar 25, 2026, 08:46 ET Alyssa Henry to Join PayPal's Board of Directors; Gail J. McGovern to Retire from Board
announced that Alyssa Henry, former CEO of Block's Square business, has joined the company's Board of Directors. The company also announced that Gail J. McGovern, who has served on the Board since 2015, will not stand for re-election at PayPal's upcoming Annual Meeting of Stockholders in May.
More news about: PayPal Holdings, Inc.
Mar 25, 2026, 08:12 ET NORD Advances Policy Leadership with Strategic Appointments to Strengthen Rare Disease Advocacy
March 25, 2026 /PRNewswire/ -- The National Organization for Rare Disorders (NORD®) today announced the appointments of Michael J. Beard as Vice President of Federal and Global Public Policy and Cara Tenenbaum, JD, MBA, as Director of Regulatory Affairs, further strengthening
More news about: National Organization for Rare Disorders (NORD®)